Coronavirus variant B.1.1.7 is currently the largest variant in the UK and there was suspicion behind the updated increase in Covid-19 cases in the country.
Le hindustantimes.com | Edited by Kunal Gaurav, New Delhi
PUBLISHED ON MAR 05, 2021 09:45 PM IST
Scientists have identified 16 other cases of new coronavirus differentiation in the UK because mutations of Sars-CoV-2 remain a greater threat to protective measures for the disease. Public Health England (PHE) has identified the new series of line B.1.1.318 as variance under study (VUI).
The UK government’s health body announced on Thursday that cases of this new variant were first identified on February 15 through a “genomic horizon scan”. He also said that all who tested positive and their acquaintances were found and advised.
Coronavirus variants are taken for formal study if they are thought to be related to epidemiological, immunological, or pathogenic properties. The new variant, which is understood to have originated in the UK, has been named VUI by year, month and number.
The VUI-202102/04 variant includes an E484K mutation, which was also found in two VUIs detected in the country. However, this new variant does not reflect the N501Y mutation that is present in all anxiety variables (VOCs). It can be designated as a VOC following a risk assessment by the relevant expert committee. Currently, Britain is monitoring 4 VUI and 4 VOC in total.
Coronavirus variant B.1.1.7 is currently the largest variant in the UK and was suspected to be behind the recent rise in cases of coronavirus (Covid-19) infection in the country. According to PHE, at least 108,337 cases of the B.1.1.7 variant have been detected in the country to date. Some experts have predicted that B.1.1.7 is likely to drive a new release wave in the spring.
The scientists have also identified six cases of a new P.1 variant, first discovered in Brazil, UK. A new modeling study has suggested that the VOC could be up to 2.2 times more potent and cause relapse in people who have already recovered from Covid-19.
Researchers at the University of São Paulo, in collaboration with Imperial College London and the University of Oxford, used statistical analysis of genome sequence data to conclude that the second wave of diseases was in Manaus Brazil, a city- The current immunity from the first wave was thought to be high, related to the appearance of the new P.1 version. The study was not peer-reviewed or published in a medical journal and is available as an introduction.